Trump’s Pharma Tariffs Spark Industry Uncertainty, Experts Skeptical
Experts question Trump’s proposed drug tariffs, citing global supply chain complexities and high U.S. production costs. Industry investments may not lower prices or boost security.
PharmaIndustry
Read More
New U.S. Drug Tariffs Spark Global Health Equity Concerns
Experts warn proposed U.S. tariffs on pharmaceuticals could raise drug prices, strain supply chains, and undermine global health equity, impacting low-income populations.
China’s Pharma Chamber Condemns US Trade Policies, Vows Global Collaboration
China’s pharmaceutical trade association opposes US tariffs, citing threats to global healthcare access and pharmaceutical industry stability.
America’s Drug Culture: Unveiling the Hidden Addiction Crisis
America faces a deepening addiction crisis fueled by aggressive pharmaceutical marketing and over-prescription of pills, highlighting the urgent need for systemic reforms.